|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Treatment of Helicobacter pylori infection: Current and future insights显示文摘Helicobacter pylori(H.pylori) is an important major cause of peptic ulcer disease and gastric malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric adenocarcinoma worldwide.H.pylori treatment still remains a challenge,since many determinants for successful therapy are involved such as individual primary or secondary antibiotics resistance,mucosal drug concentration,patient compliance,side-effect profile and cost.While no new drug has been developed,current therapy still relies on different mixture of known antibiotics and anti-secretory agents.A standard triple therapy consisting of two antibiotics and a proton-pump inhibitor proposed as the first-line regimen.Bismuthcontaining quadruple treatment,sequential treatment or a non-bismuth quadruple treatment(concomitant) are also an alternative therapy.Levofloxacin containing triple treatment are recommended as rescue treatment for infection of H.pylori after defeat of first-line therapy.The rapid acquisition of antibiotic resistance reduces the effectiveness of any regimens involving these remedies.Therefore,adding probiotic to the medications,developing anti-H.pylori photodynamic or phytomedicine therapy,and achieving a successful H.pylori vaccine may have the promising to present synergistic or additive consequence against H.pylori,because each of them exert different effects. | Maliheh Safavi Reyhaneh Sabourian Alireza Foroumadi | 2016 | World Journal of Clinical Cases2016，4，1： | 21 |
| 2 | Synthesis and anti-Helicobacter pylori activity of 5-( nitroaryl)- 1,3,4-thiadiazoles with certain sulfur containing alkyl side chain显示文摘 | Foroumadi A Rineh A Emami S | 2008 | Bioorg Med Chem Lett2008，18，11： | 1 |
| 3 | Synthesis and in vitro antifungal activity of 2-aryl-5-phenylsulfonyl-1,3,4-thiadiazoles derivatives显示文摘 | Foroumadi A Daneshtalab M Shafiee A | 1999 | Arzneim-Forsch/Drug Res1999，19，12： | 1 |
| 4 | Antituberculosis agents-II Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-( 1-methyl-5-nitro-2-imid- azolyl) -1,3,4-thiadiazole derivatives 显示文摘 | Foroumadi A Mirzaei M Shafiee A | 2001 | Farmaco2001，56，8： | 1 |
| 5 | Synthesis and in vitro antibacterial activity of some N-(5-aryl,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives显示文摘 | Foroumadi A Soltani F Moshafi MH | 2003 | Ⅱ Farmaco2003，58，： | 1 |
| 6 | 3-Imidazolyl -substituted flavans as potential antifungal agents: Synthesis, Stereochemical properties, and antifungalactivity显示文摘 | Emami S Foroumadi A | 2009 | Arch Pharm Chem Life Sci2009，342，： | 1 |
| 7 | Synthesis and in vitro antibacterial evaluation of N- piperazinyl quinolones 显示文摘 | FOROUMADI A MANSOURI S KIANI Z | 2003 | Eur J Med Chem2003，38，9： | 1 |
| 8 | Design of conformationally constrained azole antifungals: efficient synthesis and antifungal activity of trans-3-imidazolyl flavanones显示文摘 | Emami S Behdadl M Foroumadi A | 2009 | Chem Biol Drug Des2009，73，： | 1 |
| 9 | Synthesis and antibacterial activity of N-( 5-benzyhhio-1,3,4-thiadiazol2-yl ) and N- ( 5-benzylsulfonyl -1,3,4-thiadiazol-2-yl ) piperazinyl quinolone derivatives 显示文摘 | FOROUMADI A EMAMI S HASSANZADEH A | 2005 | Bioorg Med Chem Lett2005，15，20： | 1 |
| 10 | Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro- 1 H - imidazol - 2 - yl ) - 5 - substituted - 1, 3, 4 - thiadiazole derivatives显示文摘 | FOROUMADI A EMAMI S POURNOURMOHAMMADI S | 2005 | Eur J Med Chem2005，40，： | 1 |
| 11 | Functionalized N (2- oxyimino-ethyl) piperazinyl quinolones as new cytotoxic agents 显示文摘 | Rajibalian S Foroumadi A Shafiee A | 2007 | J Pharm Pharm Sci2007，10，2： | 1 |
| 12 | Synthesis and in vitro antibacterial activity of some N-(5- aryl- 1,3,4 -thiadiazole-2-yl ) piperazinyl quinolone deriva- tives 显示文摘 | FOROUMADI A SOLTANI F MOSHAFI M H | 2003 | Farmaco2003，8，10： | 1 |
| 13 | The importance of synthetic drugs for type 2 diabetes drug discovery 显示文摘 | SAFAVI M FOROUMADI A ABDOLLAHI M | 2013 | Expert Opin Drug Discov2013，8，11： | 1 |
| 14 | Synthesis and in vitro antibacterial activity of some N -(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives显示文摘 | Alireza Foroumadi Fatemeh Soltani Mohammad Hasan Moshafi Rogheeyeh Ashraf-Askari | 2003 | Il Farmaco2003，，10： | 1 |
| 15 | Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of Npiperazinyl quinolone derivatives containing 2 thienyl and 2-furyl moiety显示文摘 | Foroumadi A Soltani F Mirzaei M | 2003 | Pharmazie2003，58，5： | 1 |
| 16 | Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3,4- thiadiazolc-2-yl) piperazinyl quinolone derivati-ves 显示文摘 | Foroumadi A Soltani F Moshafi M H | 2003 | II Farmaco2003，58，10： | 1 |
| 17 | Syntheses of arylsulfonyl-1,3,4- thiadiazole显示文摘 | Shafiee A Foroumadi A | 1996 | Hete-Rocyc Chem1996，33，： | 1 |
| 18 | Synthesis of 4-(4-Methylsulfonylphenyl)-3-phenyl-2(3H)-thiazole Thione Derivatives as New Potential COX-2 Inhibitors显示文摘新奇的 4-(4-methylsulfonylphenyl ) 的合成有 functionalized diarylheterocycle pharmacophore 的 -3-phenyl-2(3H)-thiazole thione 衍生物被描述为潜在的 COX-2 禁止者。标题混合物是由相应 dithiocarbamate 和 2-bromo-1-(4-methylsulfonylphenyl ) ethanone 的 cyclocondensation 的 synth- esized,与 H2SO4 由脱水列在后面。所有被 1H NMR,红外和质量目标混合物描绘光谱数据。 | EMAMI, Saeed FOROUMADI, Alireza | 2006 | Chinese Journal of Chemistry2006，24，6： | 1 |
| 19 | Synthesis of Arylsulfonyl-l,3,4-thiadiazoles 显示文摘 | Shafiee A Foroumadi A | 1996 | Heterocycl Chem1996，33，： | 1 |
| 20 | Development and validation of a rapid HPLC-fluorescemce method for simultaneous determination of venlafaxine and its major metabolites in human plasma显示文摘 | Ardakani YH Foroumadi A Rouini MR | 2010 | DaruJ Facul Pharm2010，18，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员